Search

Subject Cyclophosphamide -- Malignancy -- Systemic sclerosis

1. Risk factors for malignancy in systemic sclerosis patients. Issue 6 (June 2016)

Authors:
Kaşifoğlu, T.; Yaşar Bilge, Ş.; Yıldız, F.; Özen, G.; Pehlivan, Y.; Yılmaz, N.; Tarhan, F.; Yılmaz, S.; Küçük, A.; Emmungil, H.; Koca, S.; Çınar, M.; Direskeneli, H.; Erken, E.; Can, G.; Özmen, M.; Gönüllü, E.; Kisacik, B.; Aksu, K.; Karadağ, O.
Journal:
Clinical rheumatology
Issue:
Volume 35:Issue 6(2016)
Page Start:
1529
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • Cyclophosphamide -- Malignancy -- Systemic sclerosis 1